What's Happening?
Fox has renewed the medical drama 'Doc' for a third season, ordering another 22 episodes. This decision follows the show's successful second season, which also featured a rare 22-episode order. 'Doc' has become a breakout hit for Fox, averaging 7.4 million
multi-platform viewers, making it the network's largest scripted audience for the 2025-26 season. The show, starring Molly Parker, is co-produced by Sony Pictures Television and Fox Entertainment Studios and is based on the Italian series 'Doc — Nelle tue mani'. The renewal highlights the show's strong performance across various platforms, including Hulu and Netflix, and its international appeal, having been sold in over 200 countries.
Why It's Important?
The renewal of 'Doc' for a third season with a full 22-episode order is significant in the current television landscape, where such orders have become rare due to cost-saving measures. This move underscores the show's popularity and the network's confidence in its continued success. For Fox, 'Doc' represents a valuable asset in its programming lineup, attracting a substantial audience and enhancing its competitive position in the market. The show's success also reflects the growing trend of international formats being adapted for U.S. audiences, highlighting the global nature of the entertainment industry. Additionally, the show's performance on streaming platforms like Hulu and Netflix indicates the importance of multi-platform distribution in reaching wider audiences.
What's Next?
With the renewal secured, 'Doc' will continue to build on its success in the upcoming season. The show's creative team, led by co-showrunners Barbie Kligman and Hank Steinberg, will likely focus on maintaining the high standards of storytelling and character development that have resonated with audiences. As the series progresses, it may explore new narrative arcs and character dynamics to keep viewers engaged. The show's international distribution and streaming deals will continue to play a crucial role in its global reach, potentially opening up new markets and opportunities for expansion. For Fox, the continued success of 'Doc' could influence future programming decisions and strategies, particularly in the realm of scripted dramas.
